This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rebuttal to overinterpretation of the antiviral results for human coronavirus 229E relative to severe acute respiratory syndrome coronavirus‐2 by Rowpar Pharmaceuticals. Issue 4 (5th January 2021)
Record Type:
Journal Article
Title:
Rebuttal to overinterpretation of the antiviral results for human coronavirus 229E relative to severe acute respiratory syndrome coronavirus‐2 by Rowpar Pharmaceuticals. Issue 4 (5th January 2021)
Main Title:
Rebuttal to overinterpretation of the antiviral results for human coronavirus 229E relative to severe acute respiratory syndrome coronavirus‐2 by Rowpar Pharmaceuticals